Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-03

FDA Approved: DICLOFENAC POTASSIUM — Original Application (Lifsa Drugs LLC)

View source ↗

Summary

FDA approved the original application for diclofenac potassium as a generic NSAID for relief of pain and inflammation associated with various conditions, manufa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DICLOFENAC POTASSIUM (diclofenac potassium)

Snippet

ORIG AP for DICLOFENAC POTASSIUM (DICLOFENAC POTASSIUM)